Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas. [electronic resource]
- Clinical nuclear medicine Sep 2015
- e448-50 p. digital
Publication Type: Case Reports; Journal Article
1536-0229
10.1097/RLU.0000000000000862 doi
Humans Hypercalcemia--etiology Male Middle Aged Neuroendocrine Tumors--complications Octreotide--analogs & derivatives Pancreatic Neoplasms--complications Radiopharmaceuticals--therapeutic use